RISIKOBASIERTE BEURTEILUNGSMUSTER

Patent europeic · EP3154419 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3154419
Numer da la dumonda
EP15800388
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-05-2015
Publitgà
19-04-2017
Concedì
11-09-2024
La protecziun finescha il pli tard
20-05-2035
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
G16H 50/30 (2018.01)
G16H 50/20 (2018.01)
G06F 18/22 (2023.01)
G06F 18/23 (2023.01)
Prioritad
US 201414291446 30.05.2014
Dumonda PCT
PCT/US2015/031965 21.05.2015
Publicaziun PCT
WO2015/183689 03.12.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 23-07-2025

    Midada

    Published in Swissreg on 23.07.2025

  3. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  4. 18-09-2024

    Midada

    Published in Swissreg on 18.09.2024

  5. 11-09-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.09.2024

  6. 11-09-2024

    Owner

    Owner
    Roche Diabetes Care GmbH, Sandhofer Straße 116, 68305 Mannheim, Germany → F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel

    Published in Swissreg on 11.09.2024

Partidas

Possessur

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventur

DUKE, David L.

Fishers, Indiana 46037, US

SONI, Abhishek

Noblesville, Indiana 46062, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.